To exclude the phenotype variation due to the various knockout efficiency, we confirmed the significant reduction of RBM5 at both mRNA and protein levels by the two individual sgRNAs in all the tested AML cell lines (Fig. 2c; Additional file 1: Fig. S2c, d). The gene discussed is RBM5; the disease is acute myeloid leukemia.